Related Experiment Video
Updated: Jun 12, 2025

08:22
Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
Published on: August 11, 2017
15.7K
[3D bioprinting: classification, evaluation, and application in vascular tissue engineering]
Xiafei Li1, Huanhuan Yan2, Tuo Yang2
1School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|September 25, 2024
Summary
3D bioprinting offers a promising solution for creating artificial blood vessels, overcoming limitations in traditional tissue engineering methods for cardiovascular disease treatments.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Engineering
Background:
- Cardiovascular diseases necessitate effective treatments, yet small-diameter artificial blood vessels for coronary artery bypass surgery remain scarce.
- Conventional vascular scaffold fabrication methods struggle with precise control over diameter, shape, and pore interconnectivity.
- Existing tissue engineering approaches for vascular grafts face significant limitations.
Purpose of the Study:
- To systematically review and evaluate 3D bioprinting technologies for vascular tissue engineering.
- To highlight the advancements and potential of 3D bioprinting in creating vascular scaffolds.
- To identify challenges and future research directions in this field.
Main Methods:
- Review of current 3D bioprinting techniques applicable to vascular tissue engineering.
- Analysis of research progress in utilizing 3D bioprinting for vascular scaffold fabrication.
- Evaluation of the advantages and limitations of 3D bioprinting in this context.
Main Results:
- 3D bioprinting allows for precise control over scaffold architecture, including nanoscale microstructure and porosity.
- It enables the accurate deposition of cells and biomaterials, mimicking natural vascular tissue structure.
- This technology offers enhanced capabilities for creating patient-specific vascular grafts.
Conclusions:
- 3D bioprinting presents a significant advancement over traditional methods for vascular tissue engineering.
- Addressing challenges like immune rejection of biomaterials is crucial for clinical translation.
- Further research is needed to optimize 3D bioprinting strategies for small-diameter vascular applications.

